BRUSSELS, BELGIUM / RankWire.AI / – In Brussels, during August, the European Commission has expanded its efforts to combat the Ebola crisis by securing a €2.1 million procurement of PCR tests targeting the Bundibugyo virus. The procurement involves open-platform testing solutions that laboratories can implement using existing infrastructure. The European Health and Digital Executive Agency backed the procurement process. Delivery of these tests is expected to commence in August, as health teams face a significant outbreak centered in the Democratic Republic of the Congo and impacting surrounding regions.
The World Health Organization will receive the testing supplies via its Hub for Global Health Emergencies Logistics located in Dubai. From there, WHO will oversee distribution to key locations involved in the Ebola response. PCR testing plays a critical role in confirming cases and supporting surveillance efforts around known infections. Health teams rely on these confirmed results to determine patient treatment, enforce isolation, and trace contacts. This latest shipment boosts laboratory capacity at a crucial time when authorities continue monitoring transmission across multiple provinces and health zones within the Democratic Republic of the Congo.
Earlier, the European Commission allocated another €2.5 million for rapid molecular point-of-care tests and testing instruments. This equipment will aid the Africa Centres for Disease Control and Prevention in regional response initiatives. Combining both diagnostic agreements, the total European support now reaches €4.6 million. These efforts are part of a broader package of aid aimed at strengthening health responses in countries affected by the Bundibugyo Ebola outbreak. The assistance includes medical supplies, preparedness initiatives, and public health resources designed to reinforce efforts across impacted and neighboring areas.
Testing capacity expands amid significant outbreak
According to WHO data, by August 12, the Democratic Republic of the Congo had reported 4,665 confirmed cases and 2,184 deaths. Infections had been identified across 54 health zones in six provinces, including Ituri, North Kivu, South Kivu, Haut-Uélé, Tshopo, and Bas-Uélé. WHO described this as the largest Ebola outbreak ever recorded in the country. The organization also noted ongoing transmission across connected geographic clusters, which continues to demand extensive efforts from surveillance teams, laboratories, treatment facilities, and local health services.
In its August update, WHO maintained a very high national risk assessment for the Democratic Republic of the Congo. The risk for neighboring countries was rated as high, while elsewhere it was considered low. Following a meeting of its International Health Regulations Emergency Committee on August 24, WHO issued updated temporary recommendations. These guidelines focus on surveillance, case detection, infection prevention, clinical management, and community engagement. They also address mobility and public gatherings during this ongoing emergency response.
European health aid reaches €493 million
The European Commission announced it has allocated €493 million to support emergency aid, vaccines, treatments, and health security initiatives across the Great Lakes and Uganda regions. European health agencies have also contributed to laboratory efforts, surveillance activities, and preparedness measures. The European Centre for Disease Prevention and Control continues to assess the risk to European populations as very low. Ebola primarily transmits through direct contact with infected bodily fluids, making rapid detection, safe clinical practices, and effective infection controls essential to curbing spread.
The Bundibugyo virus outbreak remains classified as a public health emergency of international concern under WHO’s international health framework. Currently, there is no approved vaccine or specific treatment for Bundibugyo virus disease. Consequently, health authorities continue to depend on surveillance, rapid diagnosis, isolation, clinical management, infection prevention, and close contact monitoring. The new PCR testing supplies enhance laboratory capacity to support these measures. WHO, Africa CDC, and national health agencies maintain coordinated efforts to identify cases swiftly and uphold public health measures in affected communities.